Renal lesions in HIV-1-positive patient treated with tenofovir

被引：98

作者：

Créput, C

Gonzalez-Canali, G

Hill, G

Piketty, C

Kazatchkine, M

Nochy, D

机构：

[1] Hop Europeen Georges Pompisou, Dept Pathol, Paris, France

[2] Hop Europeen Georges Pompisou, Dept Immunol, Paris, France

[3] Hop Broussais, INSERM, U430, F-75674 Paris, France

来源：

AIDS | 2003年 / 17卷 / 06期

关键词：

D O I：

10.1097/00002030-200304110-00026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：935 / 937

页数：3

共 4 条

[1] Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs [J].

Cihlar, T ;

Ho, ES ;

Lin, DC ;

Mulato, AS .

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :641-648

[2]

Dobkin JF, 2002, INFECT MED, V19, P11

[3] Cidofovir-induced end-stage renal failure [J].

Meier, P ;

Dautheville-Guibal, S ;

Ronco, PM ;

Rossert, J .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (01) :148-149

[4] Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study [J].

Schooley, RT ;

Ruane, P ;

Myers, RA ;

Beall, G ;

Lampiris, H ;

Berger, D ;

Chen, SS ;

Miller, MD ;

Isaacson, E ;

Cheng, AK .

AIDS, 2002, 16 (09) :1257-1263

← 1 →